Discrepancy in polysomnography scoring for a patient with obstructive sleep apnea hypopnea syndrome.

Department of Otolaryngology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, Japan.
The Tohoku Journal of Experimental Medicine (Impact Factor: 1.28). 09/2005; 206(4):353-60. DOI: 10.1620/tjem.206.353
Source: PubMed

ABSTRACT Overnight polysomnography (PSG) is indispensable for diagnosis of obstructive sleep apnea hypopnea syndrome. However, studies on interscorer agreement on PSG scoring between laboratories are few. The purpose of this study was to examine the reliability of interscorer agreement on PSG scoring among 16 sleep laboratories in Japan. We found a relatively moderate interscorer reliability of the index of oxygen desaturation and arousal during sleep, but a relatively low reliability of the index of transient reduction in and complete cessation of breathing (apnea hypopnea index). The median rate of interscorer coincidence of sleep staging was the lowest for slow wave (deep) sleep (23.5%), followed by those for Stage 1 (59.8%), Wake (73.2%) and Stage 2 (74.2%) in this order, and rapid eye movement was the most reliably identified stage (91.3%). The median rate of interscorer coincidence for all stages was 71.8%. The present study demonstrates that scorers tend to analyze PSG data according to a relatively empirical decision as opposed to a rule-dependent decision. Further detailed scoring manuals are required to decrease the interscorer discrepancy in PSG scoring.

Download full-text


Available from: Shintaro Chiba, Dec 20, 2013
  • [Show abstract] [Hide abstract]
    ABSTRACT: To evaluate sleep-related obstructive breathing events in patients with obstructive sleep apnea-hypopnea syndrome (OSAHS), we developed a technique for digital recording and analysis of esophageal pressure (Pes) and elucidated the Pes parameters. Pes was recorded overnight with a microtip-type pressure transducer in 74 patients with OSAHS. Simultaneously, in all patients digital polysomnography was recorded. The mean nadir end-apneic Pes swing (Pes Nadir) ranged from -20.2 to -147.4 cmH(2)O, with a mean of -53.6+/-2.9 cmH(2)O. Correlation of the mean Pes Nadir indicated a linear relationship with the mean ratio of maximal Pes swing to apnea duration (r(2)=0.70) and the mean area of the Pes (Pes Area) (r(2)=0.82). Significant correlations were noted between the mean Pes Nadir and apnea-hypopnea index (AHI, ranging from 7.9 to 109.5 per hour; r(2)=0.66), minimum SpO(2) (r(2)=0.60), oxygen desaturation index (ODI) of more than 3 (r(2)=0.65), arousal index (r(2)=0.54), and between the mean Pes Area and AHI (r(2)=0.63), minimum percutaneous arterial oxygen saturation (SpO(2); r(2)=0.57), ODI (r(2)=0.69), and arousal index (r(2)=0.41). Pes parameters were found to be significant in the evaluation of the severity of the respiratory effort during the sleep-related obstructive breathing events for patients with OSAHS.
    Sleep And Breathing 07/2005; 9(2):64-72. DOI:10.1007/s11325-005-0015-0 · 2.87 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Obstructive sleep apnea-hypopnea syndrome (OSAHS) patients undergo continuous positive airway pressure (CPAP) treatment for the first time on titration night, and then the effect of overnight CPAP treatment is estimated immediately. The purpose of this study is to compare the effects of CPAP-pretreated and non-pretreated on patients with OSAHS. Prospective randomized, controlled parallel study was performed. Seventy patients with OSAHS received autoadjusted CPAP treatment for 2 months and then received the standard manual titration (CPAP-pretreated group). The other 70 did not receive any CPAP treatment before receiving the standard manual titration (non-CPAP-pretreated group). The CPAP-pretreated group had significantly improved sleep efficiency and arousal index in non-rapid eye movement (NREM) sleep compared with the initial CPAP group at titration, whereas there were no significant differences between the two groups in other sleep parameters. Eight patients in the non-CPAP-pretreated group discontinued CPAP treatment 9 months after the titration, whereas one patient in the CPAP-pretreated group discontinued treatment. A preceding CPAP treatment showed minimal effects on sleep parameters on titration night and subsequent CPAP compliance rate, although it was speculated that this preceding treatment might be of benefit for better compliance in some patients.
    Sleep Medicine 12/2007; 8(7-8):773-8. DOI:10.1016/j.sleep.2007.01.013 · 3.10 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Sleep apnea syndrome (SAS) is basically divided into two types: obstructive and central SAS. Recently, the concept of complex SAS has been advocated. Complex SAS is defined as SAS that initially manifests as primarily obstructive SAS, but is characterized by the frequent central apneas after the removal of upper airway obstruction. To determine the prevalence and clinical significance of complex SAS among Japanese patients with SAS, 1,312 patients with SAS were enrolled in this study. Diagnosis of central SAS was made based on diagnostic polysomnography, and differentiation of obstructive SAS from complex SAS was made from polysomnographic findings for treatment with continuous positive airway pressure, which resolved upper airway obstruction. As a result, obstructive SAS was found in 1,232 of 1,312 patients with SAS (93.9%) and central SAS was found in 14 patients (1.1%). The overall prevalence of complex SAS was 5.0% (n = 66). The prevalence of complex SAS among 1,218 male and 94 female patients with SAS were 5.3% and 1.1%, respectively. Patients with complex SAS had significantly higher apnea/hypopnea indices than patients with either obstructive or central SAS, but were similar in both mean age and average body mass index to obstructive SAS patients. There were no significant between-group differences in numbers of patients with clinical complications including hypertension, cardiac diseases, or cerebrovascular diseases. In conclusion, the prevalence of complex SAS in Japanese SAS patients is 5.0%, which is lower than previously reported prevalence of complex SAS in the USA and Australia.
    The Tohoku Journal of Experimental Medicine 09/2008; 215(4):349-54. DOI:10.1620/tjem.215.349 · 1.28 Impact Factor